The lack of a continuous in vitro culture system for Plasmodium vivax severely limits our knowledge of 1 1 pathophysiology of the most widespread malaria parasite. To gain direct understanding of P. vivax 1 2 human infections, we used Next Generation Sequencing data mining to unravel parasite in vivo 1 3 expression profiles for P. vivax, and P. falciparum as comparison. We performed cloud and local 1 4 computing to extract parasite transcriptomes from publicly available raw data of human blood samples.
Introduction 1 3 0 comparisons between the two malaria diseases, in order to assess which differences between the two 1 3 1 have the most influence in producing the current epidemiological profile of the two diseases. This can 1 3 2 inform us whether our genomics research results are an important aspect of P. vivax spread within 1 3 3 populations. We categorize humans and mosquitoes into compartments based on their infection 1 3 4 status, such as Susceptible, Exposed, Asymptomatic and Infected (see Supplementary Text S1), with 1 3 5 additional compartments in the P. vivax model to account for the potential for relapses. For each 1 3 6 model we calculate ܴ , the basic reproductive number of the disease. This is a commonly used, 1 3 7 fundamental metric of disease transmission potential defined as the number of people one infected 1 3 8 person is able to infect in a susceptible population. If ܴ 1 then the disease is likely to take off and 1 3 9 spread widely throughout the population. As the models for P. vivax and P. falciparum contain many 1 4 0 similar components, we assess the relative ܴ for the diseases, i.e. we divide all values of ܴ for P. allows us to easily make comparisons between the two diseases as well as ignore potential error in parameter values for those parameters which are shared between the two models. In order to assess the impact of early transmission in humans on disease spread compared to 1 4 5 other differences between P. falciparum and P. vivax, we perform a sensitivity analysis of ܴ for P. a reduction from 14 to 7 days in the incubation period. That is, the larger ε is, the bigger a difference 1 5 0 between P. falciparum and P. vivax, indicating earlier transmission for the latter disease. The more influence that parameter has on ܴ . In this way we can compare how much effect reducing the 1 5 7
length of the intrinsic incubation period has on disease spread versus the role of asymptomatic Full details of the models created and the parameter values chosen as base values are presented 1 6 0 in S1 Text. with a single source of P. vivax, and generated whole blood RNAseq before and after the challenge. The post-infection RNAseq was produced on day 8-9 (diagnosis day), i.e., the first blood stage cycle 1 6 9
after the liver stage infection which usually lasts for about 6-7 days [7, 8] . Due to the very low levels of 1 7 0 parasitemia at this time point, we first used a cloud-based data mining pipeline to obtain pathogen 1 7 1 sequences (P. vivax) in order to investigate the feasibility of our project. We deployed the program targets to increase the search specificity. From a total of 12 pairs of pre and post infection RNAseq raw sequencing reads data sets, we successfully detected P. vivax sequences from 1,000 to almost 1 7 8 50,000 reads in post-infection samples (Fig 2A) . In contrast, none of the pre-infection samples gave a 1 7 9 significant amount of reads (> 10). From this analysis, we concluded that we could precisely recover 1 8 0 up to 50,000 P. vivax transcripts derived sequencing reads at this very early stage asexual replication. were filtered prior to implementation of the Tuxedo RNAseq pipeline. An average of 16.8% of the 1 9 0 reads can be mapped to human genome reference GRCh37. On average only 0.45% total reads on 1 9 1 average mapped to the P. vivax reference genome ( Fig 2B) . From the 12 post-infection RNAseq can identify from 9% to over 50% of the total protein-coding P. vivax genes are expressed at > 20 To confidently identify parasite derived RNAseq signal from infected host tissues, we developed a 1 9 7
Poisson Modelling (PM) method to characterize positive pathogen signals above the background. We parasite transcriptional levels with a Maximum Likelihood method (S1 and S2 Table) . To cross- Binomial Model (NBM) and obtained very similar results with only 0-2 genes expression in the control. we used a gene-by-gene PM evaluation approach to identify the significantly expressed parasite To understand the molecular patterns associated with P. vivax parasitemia, we designed a 2 0 7 computational method to search for parasitemia associated genes. First, we grouped the patients into levels of parasitemia on pre-patent day, i.e. a range of 11 -13 days [23], a few days later than the 2 1 0
RNAseq samples were collected. We recognize that, in reality, all the patients have very few parasites with the levels of parasitemia. In the top 20 in vivo parasitemia associated genes (p < 0.05), we 2 1 5
identified genes with peak expressions in different asexual stages such as ring, trophozoite and 2 1 6 schizont. We clearly identify a gametocyte expression signature at this early stage of in vivo infection in the top ranking markers. To understand the extent of gametocytogenesis gene expression and its relationship with parasite 2 2 0 abundance, we search for how many known gametocyte specific markers are expressed. We first 2 2 1 defined a set of 280 gametocyte specific genes by using P. falciparum orthologous gene expression 2 2 2 7 specificity (details in Materials and Methods). We discovered that between 8% to 60% all sexual stage 2 2 3 specific genes are expressed in this early blood stage (S1B Fig) . To further investigate the 2 2 4 gametocytogenesis transcription pattern, we identified 48 gametocyte related genes from the patient 2 2 5 infected transcriptomes. We were able to identify stage specific gametocyte markers with early 2 2 6 markers [21] such as tubulin-specific chaperone PVX_081315 and Pvs16 PVX_000930. We also 2 2 7
found late markers such as PVX_116610, indicating that there might be mixed stages of gametocyte 2 2 8 obligation at this early blood stage. Furthermore, we have found gender specific markers, such as 2 2 9 female markers like PVX_093600; as well as male markers such as PVX_116610 (S3 Table) ,
indicating that there are mixed genders of gametocytes developed from a single source of sporozoite 2 3 1 challenge. The transcriptional factor PvAP2-G is considered a master regulator and a specific marker 2 3 2 for early gametocyte production in malaria parasites [24] . We are able to clearly identity transcripts of 2 3 3
PvAP2-G in 5 patients in the early blood stage ( Fig 3A) .
To validate our findings of gametocytogenesis expression signature in vivo, we analyzed an 2 3 5
independently generated, publicly available data set of ex vivo RNAseq data from pooled infected 2 3 6 patient blood [12] . To search for relationships between expression levels and gametocyte production, expression. We first computed the average FPKM for each gene and converted the values into a rank 2 4 0 score from 0 to 100, with 100 representing the highest relative expression levels. Then we analyzed 2 4 1 the levels of gametocyte expression specificity by calculating the ratio of sexual stage FPKM vs.
2 4 2 asexual stage FPKM, the higher values indicate higher levels of sexual stage expression specificity.
4 3
We found that the gametocyte specific genes in fact are the highest expressed genes in the ex vivo 2 4 4 data ( Fig 3B) . The top quartile of most highly expressed genes in the ex vivo data consists of more 2 4 5 than 40% of gametocyte specific genes. The ex vivo data has even stronger gametocyte expression expression time in the ex vivo expression data set, we found that gametocyte specific genes are 2 4 9 mostly expressed in late schizont/early ring stage, despite the fact that these stages have the lowest strongly supports our in vivo analysis, that P. vivax parasitemia is associated with commitment to 2 5 3 gametocytemia.
5 4
We next compared our in vivo P. vivax analysis with that of P. falciparum. Similar to P. vivax 2 5 5 analysis, we have identified the top 20 transcripts associated with parasitemia from 120 whole blood 4A, B). We defined these markers by searching for the gene expression levels that are most strongly unique transcripts. We found that in contrast to P. vivax parasitemia markers, P. falciparum 2 6 0 parasitemia driven genes have peak expression only in the merozoite/early ring stages and many of to be associated with asexual cycle protein export and host red blood cell remodelling; whereas P. We performed a sensitivity analysis of the effect of different components of P. vivax disease 2 6 8 spread ( Fig 5) . The most influential parameter on ܴ , the basic reproductive number of the disease, is 2 6 9 ݇ ଶ , which determines the proportion of human hosts that recover with hypnozoites, and hence the 2 7 0 possibility of relapse. It causes ܴ to vary from less than 2.1 to over 2.5 times the values for P. understand the likelihood of asymptomatic cases in P. vivax compared to P. falciparum to accurately 2 8 7 predict differences in disease spread. The influence of these parameters highlights the importance of Our study has uncovered the earliest possible in vivo infection data of blood stage P. vivax, a 3 0 1 parasite that cannot be cultured in the laboratory. Our study is thus an example for infectious disease 3 0 2 researchers on how to use large raw sequencing data to investigate previously intractable 3 0 3 pathogenesis-related features. We used a cloud-based mining method as part of our study. This With malaria eradication always in the spotlight of the scientific and public health community, there P. falciparum data in vivo, our study used P. falciparum data without defined infection age.
3 1 5
Nevertheless, the major differences we have discovered between P. vivax and P. falciparum, in terms 3 1 6
of in vivo gene expression, suggest that P. vivax begins gametocyte production immediately upon 3 1 7
entering the blood, whereas more research is needed for early gametocyte production in P.
3 1 8
falciparum.
3 1 9
Early stage I gametocytes of P. falciparum can be initially in peripheral blood and are microscopically 3 2 0
indistinguishable from early rings [27, 28] . Yet, we did not find strong transmission expression 3 2 1 signatures. It stands to reason that the 1-2 weeks of bone marrow sequestration that P. falciparum 3 2 2 needs in order to achieve a fully transmissible stage V truly represents an advantage for P. vivax 3 2 3 transmission over P. falciparum. Further, it has been described [29] that even very few gametocytes 3 2 4
in circulation, as inferred from our study in P. vivax, can effectively mount an infection in the mosquito 3 2 5
host. For asymptomatic infections, although the evidence is mixed and it has been suggested that the 3 2 6
proportion of symptomatic and asymptomatic clinical forms is roughly similar for both species, when submicroscopic P. vivax is significantly higher than that of P. falciparum [31, 32] . Taking into account 3 2 9
that over 89% of P. vivax submicroscopic infections are said to be asymptomatic [33] , the balance in 3 3 0 terms of better asymptomatic transmissibility falls on the side of P. vivax. Altogether, these evidence 3 3 1
suggests that the differences we have discovered between P. vivax and P. falciparum, in terms of in 3 3 2 vivo gene expression, suggests that P. vivax has the ability to spread quickly to multiple hosts before Our mathematical model, which accounts for P. vivax relapses, re-enforces the idea that P. vivax 3 3 5
will be more difficult to eliminate. Hence, our results confirm the idea, held widely, that P. vivax will be 3 3 6
the last parasite standing before the goal of malaria eradication is to be achieved [3]. Our model dynamics. It can also be adapted to account for the potential evolutionary consequences of reducing or on their frequency. Further, the importance of asymptomatic carriers is interesting as P. vivax has 3 5 0 long been associated with milder disease symptoms and many patients could be asymptomatic [34] .
3 5 1
Our model highlights the importance of including the asymptomatic stage within models, even if the 3 5 2 exact proportion of hosts that will not show symptoms is unknown.
3 5 3
Overall, the unique transmission of P. vivax leads to a much higher likelihood of disease spread gametocytogenesis early in the blood stage rationally designing a treatment or vaccine targeting the 3 6 0 early blood stage will reduce transmission rates. We would like to thank Justin Gibbons, Alison Roth and John H Adams for constructive discussions. . H  e  r  m  s  e  n  C  C  ,  T  e  l  g  t  D  S  C  ,  L  i  n  d  e  r  s  E  H  P  ,  v  a  n  d  e  L  o  c  h  t  L  A  T  F  ,  E  l  i  n  g  W  M  C  ,  M  e  n  s  i  n  k  E  J  B  M  ,  e  t  a  l  .  3  7  9   D  e  t  e  c  t  i  o  n  o  f  P  l  a  s  m  o  d  i  u  m  f  a  l  c  i  p  a  r  u  m  m  a  l  a  r  i  a  p  a  r  a  s  i  t  e  s  i  n  v  i  v  o  b  y  r  e  a  l  -t  i  m  eu  a  n  t  i  t  a  t  i  v  e  P  C  R  .  3  8  0   M  o  l  e  c  u  l  a  r  a  n  d  B  i  o  c  h  e  m  i  c  a  l  P  a  r  a  s  i  t  o  l  o  g  y  .  2  0  0  1  ;  1  1  8  (  2  )  :  2  4  7  -5  1  .  d  o  i  :  h  t  t  p  s  :  /  /  d  o  i  .  o  r  g  /  1  0  .  1  0  1  6  /  S  0  1  6  6  -3  8  1   6  8  5  1  (  0  1  )  0  0  3  7  9  -6  .  3  8  2   9  .  M  i  k  o  l  a  j  c  z  a  k  S  A  ,  V  a  u  g  h  a  n  A  M  ,  K  a  n  g  w  a  n  r  a  n  g  s  a  n  N  ,  R  o  o  b  s  o  o  n  g  W  ,  F  i  s  h  b  a  u  g  h  e  r  M  ,  3  8 
